Supplement: The Launch and the Exit

THE LAUNCH AND THE EXIT By Susan Brown There's an art to creating - and selling - a life science company. Pick an invention that solves a problem and then think the enterprise through to the end so you will attract the needed investors to launch a life science company. That is the advice of Gary Kurtzman who has helped to start dozens of companies over the past 16 years. Kurtzman picks winning ventures for a living as vice president for the life sciences group

Written bySusan Brown
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Pick an invention that solves a problem and then think the enterprise through to the end so you will attract the needed investors to launch a life science company. That is the advice of Gary Kurtzman who has helped to start dozens of companies over the past 16 years.

Kurtzman picks winning ventures for a living as vice president for the life sciences group at Safeguard Scientifics, a holding company based in Wayne, Pa., that provides capital to growth-stage companies. The projects that get noticed has as much to do with the messenger as the technology, according to Kurtzman. "I like the people who have the passion. I often can't disentangle the project from the people."

Successful Strategies

Margaret Foti: Devoted to cancer research

Entrepreneurs Boldly Break New Ground

Mark Tykocinski: Open doors lead a scientist to his calling

Shire Pharmaceuticals: A Study in Exponential Growth

Many Happy Returns: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies